As of 2025-06-06, the Relative Valuation of Aurobindo Pharma Ltd (AUROPHARMA.NS) is 1,636.80 INR. This relative valuation is based on P/E multiples. With the latest stock price at 1,159.50 INR, the upside of Aurobindo Pharma Ltd based on Relative Valuation is 41.2%.
The range of the Relative Valuation is 1,429.03 - 1,921.10 INR.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 32.0x | 27.4x |
| Forward P/E multiples | 21.7x - 26.9x | 24.7x |
| Fair Price | 1,429.03 - 1,921.10 | 1,636.80 |
| Upside | 23.2% - 65.7% | 41.2% |
| Date | P/E |
| 2025-06-05 | 19.29 |
| 2025-06-04 | 18.94 |
| 2025-06-03 | 19.02 |
| 2025-06-02 | 18.92 |
| 2025-05-30 | 19.13 |
| 2025-05-29 | 19.51 |
| 2025-05-28 | 19.03 |
| 2025-05-27 | 19.77 |
| 2025-05-26 | 19.66 |
| 2025-05-23 | 19.83 |
| 2025-05-22 | 19.75 |
| 2025-05-21 | 20.01 |
| 2025-05-20 | 19.87 |
| 2025-05-19 | 20.08 |
| 2025-05-16 | 20.00 |
| 2025-05-15 | 20.31 |
| 2025-05-14 | 20.32 |
| 2025-05-13 | 20.36 |
| 2025-05-12 | 20.05 |
| 2025-05-09 | 19.29 |
| 2025-05-08 | 19.25 |
| 2025-05-07 | 19.95 |
| 2025-05-06 | 20.08 |
| 2025-05-05 | 20.63 |
| 2025-05-02 | 20.13 |
| 2025-04-30 | 20.33 |
| 2025-04-29 | 20.16 |
| 2025-04-28 | 20.80 |
| 2025-04-25 | 20.25 |
| 2025-04-24 | 20.90 |
| 2025-04-23 | 20.85 |
| 2025-04-22 | 19.79 |
| 2025-04-21 | 19.96 |
| 2025-04-17 | 19.47 |
| 2025-04-16 | 18.84 |
| 2025-04-15 | 18.92 |
| 2025-04-11 | 18.03 |
| 2025-04-09 | 17.55 |
| 2025-04-08 | 18.28 |
| 2025-04-07 | 18.25 |
| 2025-04-04 | 18.40 |
| 2025-04-03 | 19.55 |
| 2025-04-02 | 19.28 |
| 2025-04-01 | 18.75 |
| 2025-03-28 | 19.21 |
| 2025-03-27 | 19.38 |
| 2025-03-26 | 19.23 |
| 2025-03-25 | 19.89 |
| 2025-03-24 | 20.10 |
| 2025-03-21 | 19.96 |